If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
96.50    -2.60 (-2.62%)
Bid:
96.20
Ask:
96.90
Spread: 0.70 (0.728%)
Market Cap: £117.25m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Total Voting Rights

1 Mar 2021 07:00

RNS Number : 5344Q
Impax Asset Management Group plc
01 March 2021
 

 

Impax Asset Management Group plc

 

("Impax" or the "Company")

 

Total voting rights

 

In conformity with the FCA's Disclosure Guidance and Transparency Rules DTR 5.6.1, as at 28 February 2021, the Company's issued ordinary share capital and total number of voting rights, consisted of 132,596,554 ordinary shares of 1 pence each in the Company ("Ordinary Shares"). All of the shares have equal voting rights and the Company does not hold any shares in treasury.

 

The above figure of 132,596,554 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

LEI number: 213800AJDNW4S2B7E680

- Ends -

 

 

Enquiries:

 

Impax Asset Management Group plc

Ian Simm, Chief Executive

Paul French, Director of Communications

p.french@impaxam.com

 

 

+44 (0)20 3912 3000

+44 (0)20 3912 3032

Montfort Communications

Gay Collins

Louis Supple

impax@montfort.london

 

 

+44 (0)77 9862 6282

+44 (0)77 3943 0102

Peel Hunt LLP, Nominated Adviser

James Britton or Rishi Shah

 

+44 (0)20 7418 8900

 

 

Notes to Editors - About Impax Asset Management

 

Impax Asset Management manages or advises on both listed and private markets strategies. The Company's investments are based on the strong conviction that population dynamics, resource scarcity, inadequate infrastructure and environmental constraints will profoundly shape global markets, creating investment risks and opportunities. Impax expects that these trends, reflecting the transition towards a more sustainable global economy, will drive earnings growth for well-positioned companies. Impax's proprietary investment framework identifies and calibrates the rising risks and expanding opportunities from this transition and guides the search for investments that will deliver long term outperformance.

 

For further information please visit www.impaxam.com.

 

Issued in the UK by Impax Asset Management Group plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange. Impax Asset Management Group plc is registered in England & Wales, number 03262305. AUM relates to Impax Asset Management Limited, Impax Asset Management (AIFM) Limited and Impax Asset Management LLC. Impax Asset Management Limited and Impax Asset Management (AIFM) Limited are authorised and regulated by the Financial Conduct Authority and are wholly owned subsidiaries of Impax Asset Management Group plc. Please note that the information provided and links from it should not be relied upon for investment purposes.

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRDZGZZMVRGMZM
Date   Source Headline
2nd Jun 20236:01 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20223:33 pmRNSHolding(s) in Company
16th Dec 20224:46 pmRNSNotice of AGM
13th Dec 20223:02 pmRNSHolding(s) in Company
1st Dec 20225:06 pmRNSPublication of Annual Financial Report
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSFinal Results
25th Nov 20227:00 amRNSinvestor Presentation of Full Year Results
23rd Nov 20227:00 amRNSNotice of results
21st Nov 20225:05 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSAUM update
3rd Oct 20228:22 amRNSHolding(s) in Company
13th Sep 202210:49 amRNSHolding(s) in Company
9th Sep 20221:32 pmRNSHolding(s) in Company
2nd Sep 20223:34 pmRNSHolding(s) in Company
12th Aug 20229:37 amRNSDirector/PDMR Shareholding
21st Jul 20225:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSAUM update
6th Jul 20221:50 pmRNSDirector/PDMR and PCA Shareholding
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSBoard Appointment
16th Jun 20224:37 pmRNSDirector/PDMR and PCA Shareholding
14th Jun 20227:00 amRNSHolding(s) in Company
7th Jun 20224:36 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSInterim results to 31 March 2022
12th May 20228:16 amRNSHolding(s) in Company
12th May 20227:00 amRNSInvestor Presentation of Interim Results
6th May 20227:00 amRNSDate of Interim Results
26th Apr 20223:37 pmRNSHolding(s) in Company
20th Apr 20222:11 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSAUM update
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20226:10 pmRNSResult of AGM
4th Mar 20222:30 pmRNSDirector/PDMR and PCA Shareholding
25th Feb 20227:00 amRNSAIM Rule 17 Schedule Two (g) Update
14th Feb 20221:24 pmRNSDistribution agreement
10th Jan 20227:00 amRNSAUM update
20th Dec 20216:04 pmRNSNotice of Annual General Meeting ("AGM")

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.